Nephrodite Wins FDA Breakthrough Device Designation for “Holly”

This investigational implantable, continuous dialysis device has completed its first large animal trials. The company plans to do Good Laboratory Practice studies followed by applying to regulators for first-in-human clinical trials.

Read the full article » | Posted 01-16-2026

Related Articles

• Byonyks’ X1 APD Cycler Received FDA 510(k) Approval Last Summer Posted 02-17-2026
• FDA granted 510(k) approval to Outset for Next generation Tablo with Cybersecurity Posted 02-17-2026
• Drs. Monica Farcus and Jeffrey Perl Win the Mitchell Award for Health System Innovation Posted 01-16-2026
• Meet the Dutch Neokidney: a New Suitcase Hemodialysis Machine Posted 01-16-2026